Literature DB >> 2115849

The cyclooxygenase theory of aspirin-induced asthma.

A Szczeklik1.   

Abstract

Aspirin-induced asthma is a distinct clinical syndrome which affects about 10% of adult asthmatics. In these patients aspirin and several other analgesics precipitate asthmatic attacks. The idea that the attacks might result from the specific inhibition of a single enzyme, namely cyclooxygenase, has gained both experimental and clinical support. It stimulated a number of hypotheses on the mechanism of bronchoconstriction. All these hypotheses, here discussed, operate within the framework of the cyclooxygenase theory. Their major assumption is that inhibition of cyclooxygenase triggers specific biochemical reactions which lead to open asthma attacks.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2115849

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  31 in total

1.  The aspirin disease.

Authors:  D Schiavino; E Nucera; A Milani; M Del Ninno; A Buonomo; J Sun; G Patriarca
Journal:  Thorax       Date:  2000-10       Impact factor: 9.139

Review 2.  Clinical features and diagnosis of aspirin induced asthma.

Authors:  A Szczeklik; E Nizankowska
Journal:  Thorax       Date:  2000-10       Impact factor: 9.139

3.  Aspirin induced adverse skin reactions: new pathophysiological aspects.

Authors:  B Wedi; A Kapp
Journal:  Thorax       Date:  2000-10       Impact factor: 9.139

4.  Association of Leukotriene C4 Synthase A-444C Polymorphism with Asthma and Asthma Phenotypes in Romanian Population.

Authors:  Elene Camelia Berghea; Luis O Popa; Monica I Dutescu; Mihaela Meirosu; Ileana C Farcasanu; Florian Berghea; Constantin Bara; Olivia M Popa
Journal:  Maedica (Buchar)       Date:  2015-06

Review 5.  Aspirin-induced asthma: clinical aspects, pathogenesis and management.

Authors:  Ahmed M Hamad; Amy M Sutcliffe; Alan J Knox
Journal:  Drugs       Date:  2004       Impact factor: 9.546

6.  Protection of leukotriene receptor antagonist against aspirin-induced bronchospasm in asthmatics.

Authors:  Jong Sook Park; An Soo Jang; Sung Woo Park; Young Mok Lee; Soo Taek Uh; Yong Hoon Kim; Ji Yean Cha; Se Min Park; Choon-Sik Park
Journal:  Allergy Asthma Immunol Res       Date:  2009-12-30       Impact factor: 5.764

7.  Aspirin-exacerbated asthma.

Authors:  Mathew Varghese; Richard F Lockey
Journal:  Allergy Asthma Clin Immunol       Date:  2008-06-15       Impact factor: 3.406

Review 8.  Adverse reactions to aspirin and nonsteroidal antiinflammatory drugs (NSAIDs).

Authors:  Ronald A Simon; Jennifer Namazy
Journal:  Clin Rev Allergy Immunol       Date:  2003-06       Impact factor: 8.667

Review 9.  Efficacy and tolerability of nimesulide in asthmatic patients intolerant to aspirin.

Authors:  S Bianco; M Robuschi; G Petrigni; M Scuri; M G Pieroni; R M Refini; A Vaghi; P S Sestini
Journal:  Drugs       Date:  1993       Impact factor: 9.546

10.  Genetic effect of CysLTR2 polymorphisms on its mRNA synthesis and stabilization.

Authors:  Jeong-Ah Shin; Hun Soo Chang; Se-Min Park; An-Soo Jang; Sung Woo Park; Jong Sook Park; Soo-Taek Uh; Gune Il Lim; Taiyoun Rhim; Mi-Kyeong Kim; Inseon S Choi; Il Yup Chung; Byung Lae Park; Hyoung Doo Shin; Choon-Sik Park
Journal:  BMC Med Genet       Date:  2009-10-20       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.